Quarterly Result29 May 2026, 05:53 pm
Genomic Valley Biotech Approves FY26 Audited Financial Results
AI Summary
Genomic Valley Biotech Ltd's Board of Directors approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. The board also approved the appointment of Mr. Navjyoti Kumar Jha as the Internal Auditor for the F.Y. 2026-27. The meeting commenced at 04:00 P.M. and concluded at 05:20 P.M.
Key Highlights
- Standalone audited financial results for FY26 approved.
- Mr. Navjyoti Kumar Jha appointed as Internal Auditor for F.Y. 2026-27.
- Auditor's report on the financial results is enclosed.
- Meeting commenced at 04:00 P.M. and concluded at 05:20 P.M.
Price Impact
More from GVBL